Firms

Portfolio Ventures

London, GB

portfolio.ventures

signal.nfx.com

goldi.ai

London institutional angel investor operating the PV Angel Fund and SPVs. The current official site specifies GBP 200k–500k checks in fintech and B2B software, pre-seed through Series A. Its showcased companies combine fund and personal angel track records; a homepage listing alone does not identify the legal investing vehicle. The GBP 100k historical lower bound comes from 2022 reporting.

Founded: —
Type: Venture capital

Funds1

Second PV Angel Fund2022-08-122022-08-12—
ClosedoverGBP5Mdeploymentcapital reported, exactcommitmentsunknown; amountnullavoidexactclaim; notagencyGBP80Mcompanyfundraising orAUM.

Team

Will Brooks Portfolio Ventures, unknown	$25K$5K – $50K	London
Fergal Creed Portfolio Ventures, Investor (LP)	—— – —
James Pringle Portfolio Ventures, Partner	—— – —
Will Martin Portfolio Ventures, Portfolio Ventures	—— – —

Investments

team@apexlogos.ai2 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and stages | Vehicle or metric | Amount/status | Date and evidence | Interpretation | | --- | --- | --- | --- | | Second PV Angel Fund | Over **GBP £5 million**, closed; deployment capital reported | 2022-08-12, [UKTN closure report](https://www.uktech.news/funding/vc-funding/portfolio-ventures-fund-20220812) | Latest-known dated fund closure verified in this pass, not an assertion that no later fund exists. The report says over £5m available to invest and that the second fund closed; no more exact final commitment figure was disclosed. | | Current PV Angel Fund/SPV cheque size | **GBP £200k–£500k** | [Official homepage](https://www.portfolio.ventures/), undated, accessed 2026-10-06 | Per-company cheque range, not fund size or AUM. | | Historical second-fund cheque range | **GBP £100k–£500k** | UKTN, 2022-08-12, above | Explains the older Adex description. | | Aggregate capital raised for companies | Over £80m across 240+ early-stage companies, agency case-study claim | [2025 site-design case study](https://www.awakeagency.dev/projects/portfolio-ventures), accessed 2026-10-06 | Not independently verified fund commitments, AUM or cash available. Do not treat as fund size. | The 2022 fund report specifies UK pre-seed through Series A in fintech, insurtech and SaaS. It names RePlan, Juno and Passionfruit as the first three second-fund investments. The current homepage retains pre-seed to Series A and says 15–20 deals yearly through the fund and SPVs. Searches for newer funds, third funds, and 2024–2026 fund announcements found no stronger dated close amount. Current first-fund size, total AUM and remaining deployment capacity are missing. [UKTN, 2022-08-12](https://www.uktech.news/funding/vc-funding/portfolio-ventures-fund-20220812); [official homepage, accessed 2026-10-06](https://www.portfolio.ventures/). Historical participation can extend beyond the stated entry range: reporting identifies Portfolio Ventures in Swap's **$40m Series B** in March 2025. This supports a historical later-round participation, not a general expansion of the current entry mandate. [Axios, 2025-03-04](https://www.axios.com/newsletters/axios-pro-rata-e8a355d6-6ccd-4b7a-92bc-65bad6c813e8). Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Second PV Angel Fund | Undisclosed / unverified | 2022-08-12 |
team@apexlogos.ai2 hours ago
Match research 2026-10-06 / PortfolioVentures / sha256:f89d312c3305d98de8a2252581ccd42f5ed353da471b2537360df535fd41a937 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. **thymia is a material adjacent lead.** Its official site describes voice biomarkers for depression, anxiety, stress, fatigue and broader physical-health states, developed through R&D and clinical validation. This supports neuroscience-related/mental-health assessment and digital biomarker relevance, but voice/behavioral inference is not direct brain recording or stimulation. Marketing accuracy/validation claims were not independently clinically assessed. [Official thymia homepage, undated, accessed 2026-10-06](https://thymia.ai/). Will Brooks' Signal experience list names thymia as an investor position. More usefully, his current search-indexed professional profile explicitly says the **PV Fund** portfolio includes thymia, while separately discussing his and Will Martin's personal angel investments. This is a founder's self-attributed fund investment claim, stronger than role inference but not an independently corroborated round announcement. Direct LinkedIn fetch failed; the statement was accessible only in the search index. Amount, date, round and vehicle are unresolved. Treat thymia as **self-attributed fund exposure to adjacent mental-health/voice-biomarker technology, pending round verification**, not verified direct neurotech. [Will Brooks profile, undated, search-index accessed 2026-10-06](https://uk.linkedin.com/in/will-brooks123); [Signal profile, undated, index accessed 2026-10-06](https://signal.nfx.com/investors/will-brooks). Bitfount's medical-imaging and clinical-trial infrastructure is health-related and could support multiple research fields, but the sources above do not establish specific neural/brain products or neuroscience drug-discovery exposure. Do not infer neurotech from medical imaging alone. ## Conflicts, missing information and later Adex review 1. **High-priority attribution review:** Sateliot source names Global Portfolio Investments; review/remove the PortfolioVentures participation only after a later authorized database audit. This task makes no database changes. 2. **Cheque range:** Current official £200k–£500k supersedes the £100k lower bound in the old description for current strategy; preserve the earlier range as a 2022 historical fact. 3. **Fund capital:** Record second Angel Fund closure as over £5m, announced August 2022, with latest-known caveat. Do not substitute company financing headlines, the agency's aggregate £80m figure, personal angel checks, or round totals for fund size/AUM. 4. **Duplicates/stages:** Review SeeChange/Seechange Technologies and the 2023 seed-extension label; review Orbital identities, Yonda identities and Passionfruit entries before deduplication. Thingtrax's company calls its July 2023 financing pre-Series A while Concentric calls it Series A. 5. **Team attribution:** Verify Will Brooks/Will Martin founder roles against official/historical evidence rather than leaving Brooks' baseline title unknown. An LP listing for Fergal Creed is not evidence of an investing decision-maker role. James Pringle's present status remains unverified here. 6. **Neurotech lead:** Locate an official thymia round announcement or Portfolio Ventures investment post that gives date, stage and vehicle. The founder's searchable profile provides a lead but not transactional verification. Its adjacent category should remain distinct from direct neurotechnology. 7. **Firm versus angel portfolio:** Official homepage combines the fund and angel track record; do not assign every showcased company to the fund. Partners' personal investments and prior-employer investments require separate attribution. 8. **Access limits:** NFX firm page is sparse; Signal person and LinkedIn were search-index accessible after direct-fetch failures. The older snapshot's Goldi co-investor claim was not independently verified and does not establish deep-tech investment attribution. Remaining AUM, newer fund closes, individual cheque allocations and complete current portfolio are unknown. ## Source register All sources accessed 2026-10-06. Inline links carry the specific claims; this register records provenance and dates for later review. | Source | Publication date | Access and use | | --- | --- | --- | | [Portfolio Ventures official](https://www.portfolio.ventures/) | Undated | Direct read; current identity, strategy, cheque size, fund/angel distinction. | | [NFX firm](https://signal.nfx.com/firms/portfolio-ventures) | Undated | Direct read; London identity, sparse page. | | [Will Brooks on NFX](https://signal.nfx.com/investors/will-brooks) | Undated | Search index only; founder, personal check range, experience leads. | | [UKTN fund closure](https://www.uktech.news/funding/vc-funding/portfolio-ventures-fund-20220812) | 2022-08-12 | Direct read; closed second fund, over £5m, original mandate. | | [SeeChange release](https://seechange.com/seechange-technologies-raises-8m-in-seed-extension-funding-to-transform-global-retail-with-vision-ai/) | 2023-11-21 | Direct read; exact firm investor, seed extension, vision AI. | | [Thingtrax release](https://thingtrax.com/resource/thingtrax-has-raised-4-3m-to-empower-manufacturers-to-build-the-factories/) | 2023-07-20 | Direct read; exact firm investor, industrial technology. | | [Concentric Thingtrax](https://concentric.vc/news/new-investment-thingtrax/) | 2023-07-25 | Search-index read; attribution corroboration and stage discrepancy. | | [Bitfount report](https://www.eu-startups.com/2025/07/londons-bitfount-e6-8-million-to-break-down-clinical-research-data-silos-with-federated-ai-network/) | 2025-07-23 | Direct read; investor and round, technical applications. | | [Bitfount official](https://www.bitfount.com/) | Undated | Direct read; technology verification. | | [Sateliot report](https://www.eu-startups.com/2025/03/sateliots-space-leap-e70-million-to-connect-the-planet-with-5g-iot-from-orbit/) | 2025-03-26 | Direct read; different investor identity. | | [thymia official](https://thymia.ai/) | Undated | Direct read; adjacent voice biomarkers/mental health. | | [Will Brooks professional profile](https://uk.linkedin.com/in/will-brooks123) | Undated | Search-index only; self-attributed PV Fund thymia exposure. | | [Axios Swap](https://www.axios.com/newsletters/axios-pro-rata-e8a355d6-6ccd-4b7a-92bc-65bad6c813e8) | 2025-03-04 | Search-index read; Series B historical participation. | | [Awake case study](https://www.awakeagency.dev/projects/portfolio-ventures) | Project year 2025; article undated | Search-index read; aggregate fundraising claim only, not fund size. |
team@apexlogos.ai2 hours ago
Match research 2026-10-06 / PortfolioVentures / sha256:f89d312c3305d98de8a2252581ccd42f5ed353da471b2537360df535fd41a937 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Portfolio Ventures - Exact Adex ID: `PortfolioVentures` - Canonical Adex URL: https://adex.page/firms/PortfolioVentures - Research date: 2026-10-06 - Status: Complete research pass; unresolved items explicitly retained below. ## Identity and assessment Portfolio Ventures is a London institutional angel investor operating the PV Angel Fund and SPVs, with fintech and B2B software as its stated focus. Its official site identifies Portfolio Ventures Limited, England and Wales company 08997003, and FCA reference 983413. Current website strategy spans pre-seed to Series A, with the headline specifically emphasizing Seed fintech, SaaS and vertical AI. It has verified technically substantive investments in SeeChange, Thingtrax and Bitfount, but public evidence does not establish a broad hardware or direct neurotechnology mandate. [Official website, undated, accessed 2026-10-06](https://www.portfolio.ventures/). ## Adex and NFX Signal starting evidence The saved exact-ID Adex snapshot `data/research/_sources/PortfolioVentures.adex.json`, retrieved 2026-10-06 at 19:29:34 UTC via read-only Search, describes £100k–£500k UK fintech, insurtech, SaaS and enterprise software investments, pre-seed through Series A. Its investorProfile monetary fields are null; it contains 35 investment participation entries and team roles for Will Martin, Fergal Creed (LP), James Pringle and Will Brooks (unknown title). These are baseline claims rather than independent verification. The investment list contains potential duplicates: SeeChange/Seechange Technologies, Orbital Inc./Orbital Witness, Yonda/Yonda Tax and two Passionfruit entries. [NFX Signal firm page](https://signal.nfx.com/firms/portfolio-ventures) was directly read on 2026-10-06. Accessible content confirms London but provides little beyond identity and a co-investor heading, without reliable fund-size or full portfolio detail. [Will Brooks' Signal profile](https://signal.nfx.com/investors/will-brooks), accessed through search index on 2026-10-06 after direct fetch returned an internal error, identifies him as founder at Portfolio Ventures. It states a $5k–$50k personal investment range and $25k sweet spot, and lists experience at Thingtrax, SeeChange, Bitfount and thymia. Its total-investment counts are internally inconsistent (62 versus 60 displayed). Personal check sizes and investor-role lists must not be copied into the firm's fund facts. Signal claims are leads, not independent attribution proof. ## Fund size and stages | Vehicle or metric | Amount/status | Date and evidence | Interpretation | | --- | --- | --- | --- | | Second PV Angel Fund | Over **GBP £5 million**, closed; deployment capital reported | 2022-08-12, [UKTN closure report](https://www.uktech.news/funding/vc-funding/portfolio-ventures-fund-20220812) | Latest-known dated fund closure verified in this pass, not an assertion that no later fund exists. The report says over £5m available to invest and that the second fund closed; no more exact final commitment figure was disclosed. | | Current PV Angel Fund/SPV cheque size | **GBP £200k–£500k** | [Official homepage](https://www.portfolio.ventures/), undated, accessed 2026-10-06 | Per-company cheque range, not fund size or AUM. | | Historical second-fund cheque range | **GBP £100k–£500k** | UKTN, 2022-08-12, above | Explains the older Adex description. | | Aggregate capital raised for companies | Over £80m across 240+ early-stage companies, agency case-study claim | [2025 site-design case study](https://www.awakeagency.dev/projects/portfolio-ventures), accessed 2026-10-06 | Not independently verified fund commitments, AUM or cash available. Do not treat as fund size. | The 2022 fund report specifies UK pre-seed through Series A in fintech, insurtech and SaaS. It names RePlan, Juno and Passionfruit as the first three second-fund investments. The current homepage retains pre-seed to Series A and says 15–20 deals yearly through the fund and SPVs. Searches for newer funds, third funds, and 2024–2026 fund announcements found no stronger dated close amount. Current first-fund size, total AUM and remaining deployment capacity are missing. [UKTN, 2022-08-12](https://www.uktech.news/funding/vc-funding/portfolio-ventures-fund-20220812); [official homepage, accessed 2026-10-06](https://www.portfolio.ventures/). Historical participation can extend beyond the stated entry range: reporting identifies Portfolio Ventures in Swap's **$40m Series B** in March 2025. This supports a historical later-round participation, not a general expansion of the current entry mandate. [Axios, 2025-03-04](https://www.axios.com/newsletters/axios-pro-rata-e8a355d6-6ccd-4b7a-92bc-65bad6c813e8). ## Verified previous deep-tech investments Classification below is a research judgment based on the technology, rather than simply treating all AI/SaaS as deep tech. Funding amounts are whole rounds; Portfolio Ventures' individual contribution and exact legal vehicle are not disclosed. | Company | Technology rationale | Firm attribution and round | Sources and dates | | --- | --- | --- | --- | | **SeeChange Technologies / SeeChange** | Real-time computer vision platform processing existing CCTV and checkout video for product recognition, theft detection and retail operations. Strong applied computer-vision evidence; software deployed against physical environments, not proof of a hardware investment. | Official company announcement explicitly names **Portfolio Ventures as a new investor** in the **GBP £8m (US$10m) seed extension** led by Crane Venture Partners and Triple Point Ventures. | [Official investee announcement, 2023-11-21](https://seechange.com/seechange-technologies-raises-8m-in-seed-extension-funding-to-transform-global-retail-with-vision-ai/), accessed 2026-10-06. Prefer its seed-extension description over secondary databases calling the same raise Series A. | | **Thingtrax** | Industrial IoT, AI, computer vision and robotics integrated into factory monitoring and performance optimization. Strong industrial-technology relevance, although sold as SaaS; no independent patent/novelty assessment undertaken. | Company explicitly names **Portfolio Ventures** alongside Haatch and Vinci in **GBP £4.3m pre-Series A**, co-led by Concentric, SuperSeed and Puma Private Equity. | [Official investee announcement, 2023-07-20](https://thingtrax.com/resource/thingtrax-has-raised-4-3m-to-empower-manufacturers-to-build-the-factories/); [Concentric confirmation, 2023-07-25](https://concentric.vc/news/new-investment-thingtrax/), both accessed 2026-10-06. Concentric calls it Series A; retain the company wording and discrepancy. | | **Bitfount** | Privacy-preserving federated AI allows hospitals, pharmaceutical companies and researchers to run models against sensitive records and medical images without centralizing raw patient data. Technically substantive AI/data infrastructure with clinical research applications. | EU-Startups explicitly names **Portfolio Ventures** among participants in **EUR €6.8m Series A**, 2025-07-23; monetary equivalents reported elsewhere as US$8m. No firm cheque disclosed. | [EU-Startups report, 2025-07-23](https://www.eu-startups.com/2025/07/londons-bitfount-e6-8-million-to-break-down-clinical-research-data-silos-with-federated-ai-network/); [official technology website, undated](https://www.bitfount.com/), accessed 2026-10-06. Official website read supports technology; round attribution is reputable reporting rather than a directly located official company funding release. | **Rejected attribution: Sateliot.** The saved Adex snapshot records Portfolio Ventures against the 2025-03-26 satellite financing. Its own cited report names **Global Portfolio Investments**, a different investor, alongside Hyperion and others, rather than Portfolio Ventures. Satellite 5G-IoT is deep tech, but this firm attribution is unsupported and likely a name-match error. Do not count Sateliot as a verified Portfolio Ventures investment. [EU-Startups, 2025-03-26](https://www.eu-startups.com/2025/03/sateliots-space-leap-e70-million-to-connect-the-planet-with-5g-iot-from-orbit/), directly read 2026-10-06. Other baseline software investments, such as tax/compliance automation, conveyancing AI, legal-access platforms, commerce software and procurement systems, were not automatically classified as deep tech. Not every baseline participation was independently re-audited in this focused research pass. ## Neurotech and adjacent evidence **No verified neurotech investment found in the sources checked.** No firm-attributed brain interface, neural recording, neuromodulation or direct brain-device investment was verified. This is a bounded research result, not a claim that no such investments exist.
team@apexlogos.ai22 days ago
MATCH

$—2026-02-11	Overmind	Portfolio Ventures
$—2026	Infrawatch	Portfolio Ventures, Triple Point Ventures
$—2025-12-12	Conveyd	Portfolio Ventures
$—2025-12-04	Curvestone	Portfolio Ventures
$—2025-11-26	Monq	Portfolio Ventures
$—2025-10-08	Dragonfly	Portfolio Ventures
$—2025-09-22	Yaso	Founders Fund, Hanaco Ventures, Playfair Capital, Sequel, Portfolio Ventures, Puma Growth Partners
$8M2025-07-23	Bitfount	Pace Ventures, Marius Swart, Portfolio Ventures
$—2025-06-02	Valla	Portfolio Ventures
$—2025-03-25	Burbank	Afore Capital, Portfolio Ventures
$40M2025-03-04	Swap	ICONIQ Capital, BNVT Capital, Portfolio Ventures, Dinika Mahtani, Seth Pierrepont
$—2024-07-23	Passionfruit	Portfolio Ventures
£4M2023-07-20	Thingtrax	Portfolio Ventures
$—2023-05-19	Orbital Inc.	Portfolio Ventures
$—2023-05-18	Deployed	Portfolio Ventures
$—2023-03-28	Connect Earth	Portfolio Ventures
$—2022-11-08	5mins	AlbionVC, Blue Lion Global, Portfolio Ventures
$—2022-05-25	Crowd Data Systems	Triple Point Ventures, Portfolio Ventures
$—2022	Crowd Data Systems	Triple Point Ventures, Portfolio Ventures
$—2022	Passionfruit	Accel, Atomico, Notion Capital, Portfolio Ventures
$—Unknown date	Harriet	Portfolio Ventures
$—Unknown date	DeepStream	Portfolio Ventures
$—Unknown date	Seechange Technologies	Portfolio Ventures
$—Unknown date	Ehab	Portfolio Ventures
$—Unknown date	Konfir	Portfolio Ventures
$—Unknown date	Jove	Portfolio Ventures
$—Unknown date	Eolas Medical	Portfolio Ventures
$—Unknown date	Paypercut	Portfolio Ventures
$—Unknown date	Orbital Witness	Portfolio Ventures
$—2026-07-14	Prolo	Portfolio Ventures, Triple Point Ventures
$—2025-12-11	Yonda Tax	Portfolio Ventures
£8M2023-11-21	SeeChange	Triple Point Ventures, Crane Venture Partners, Portfolio Ventures
$—Unknown date	Yonda	Portfolio Ventures
$—Unknown date	Bourn	Portfolio Ventures

Funds1

Team

Co-investing

Investments